254 related articles for article (PubMed ID: 20740675)
21. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
22. Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system.
Elsayed A; Al-Remawi M; Maghrabi I; Hamaidi M; Jaber N
Int J Pharm; 2014 Jan; 461(1-2):448-58. PubMed ID: 24368103
[TBL] [Abstract][Full Text] [Related]
23. Inclusion and release of fenbufen in mesoporous silica.
Carriazo D; del Arco M; Fernández A; Martín C; Rives V
J Pharm Sci; 2010 Aug; 99(8):3372-80. PubMed ID: 20232455
[TBL] [Abstract][Full Text] [Related]
24. [Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix].
Wu QL; Quan GL; Hong Y; Wu LN; Zeng YM; Li G; Pan X; Wu CB
Yao Xue Xue Bao; 2015 Apr; 50(4):492-9. PubMed ID: 26223134
[TBL] [Abstract][Full Text] [Related]
25. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery.
Park SB; Joo YH; Kim H; Ryu W; Park YI
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():64-73. PubMed ID: 25746247
[TBL] [Abstract][Full Text] [Related]
26. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
[TBL] [Abstract][Full Text] [Related]
27. Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.
Mellaerts R; Roeffaers MB; Houthoofd K; Van Speybroeck M; De Cremer G; Jammaer JA; Van den Mooter G; Augustijns P; Hofkens J; Martens JA
Phys Chem Chem Phys; 2011 Feb; 13(7):2706-13. PubMed ID: 21152589
[TBL] [Abstract][Full Text] [Related]
28. Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field.
Bringas E; Köysüren Ö; Quach DV; Mahmoudi M; Aznar E; Roehling JD; Marcos MD; Martínez-Máñez R; Stroeve P
Chem Commun (Camb); 2012 Jun; 48(45):5647-9. PubMed ID: 22543447
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
[TBL] [Abstract][Full Text] [Related]
30. Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silica.
Wang Z; Chen B; Quan G; Li F; Wu Q; Dian L; Dong Y; Li G; Wu C
Int J Nanomedicine; 2012; 7():5807-18. PubMed ID: 23209366
[TBL] [Abstract][Full Text] [Related]
31. Novel functional mesoporous silica nanoparticles loaded with Vitamin E acetate as smart platforms for pH responsive delivery with high bioactivity.
Mai Z; Chen J; Hu Y; Liu F; Fu B; Zhang H; Dong X; Huang W; Zhou W
J Colloid Interface Sci; 2017 Dec; 508():184-195. PubMed ID: 28841476
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
[TBL] [Abstract][Full Text] [Related]
33. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.
Nairi V; Medda L; Monduzzi M; Salis A
J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049
[TBL] [Abstract][Full Text] [Related]
34. The applicability of ordered mesoporous SBA-15 and its hydrophobic glutaraldehyde-bridge derivative to improve ibuprofen-loading in releasing system.
Rehman F; Volpe PL; Airoldi C
Colloids Surf B Biointerfaces; 2014 Jul; 119():82-9. PubMed ID: 24819430
[TBL] [Abstract][Full Text] [Related]
35. Direct surface grafting of mesoporous silica nanoparticles with phospholipid choline-containing copolymers through chain transfer free radical polymerization and their controlled drug delivery.
Huang L; Wu J; Liu M; Mao L; Huang H; Wan Q; Dai Y; Wen Y; Zhang X; Wei Y
J Colloid Interface Sci; 2017 Dec; 508():396-404. PubMed ID: 28843929
[TBL] [Abstract][Full Text] [Related]
36. Controlled release of vitamin B2 using mesoporous materials functionalized with amine-bearing gate-like scaffoldings.
Bernardos A; Aznar E; Coll C; Martínez-Mañez R; Barat JM; Marcos MD; Sancenón F; Benito A; Soto J
J Control Release; 2008 Nov; 131(3):181-9. PubMed ID: 18727946
[TBL] [Abstract][Full Text] [Related]
37. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
38. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.
Yang P; Quan Z; Lu L; Huang S; Lin J
Biomaterials; 2008 Feb; 29(6):692-702. PubMed ID: 17996294
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed.
Almáši M; Beňová E; Zeleňák V; Madaj B; Huntošová V; Brus J; Urbanová M; Bednarčík J; Hornebecq V
Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110552. PubMed ID: 32228921
[TBL] [Abstract][Full Text] [Related]
40. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]